STK33 and colorectal carcinoma: In order to interrogate the levels of STK33 in tumor specimens, our study involved a cohort of 68 patients with colorectal cancer (CRC) as well as a set of 61 patients with pancreatic ductal adenocarcinoma (PDAC) (Figure 1A and 1B).